The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus.
Autors
Lior Laver, Giuseppe Filardo, Mikel Sanchez, Jeremy Magalon, Thomas Tischer, Ferran Abat, Ricardo Bastos, Ramon Cugat, Micahel Iosifidis, Baris Kocaoglu, Elizaveta Kon, Rodica Marinescu, Marko Ostojic, Philippe Beaufils, Laura de Girolamo
Abstract
The aim of this European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) consensus is to provide recommendations based on evidence and expert opinion to improve indications, decision-making and administration-related aspects when using blood-derived orthobiologics (for simplicity indicated as PRP-platelet-rich plasma-with PRP being the most common product) for the management of knee osteoarthritis (OA).
infos +
The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA‐ORBIT consensus. Part 1—Blood‐derived products (platelet‐rich plasma)
